InvestorsHub Logo
Followers 39
Posts 13337
Boards Moderated 1
Alias Born 12/09/2015

Re: None

Saturday, 01/02/2021 12:25:04 PM

Saturday, January 02, 2021 12:25:04 PM

Post# of 5
Astellas Innovation Management (AIM) sounds like a partnership program that would target a company with a product like AAGP.
AAGP has been proven “remarkably safe” in human clinical trials and those trials have seen a possible benefit regarding TAC.

I think we have a winner!